FDA panel votes against new Avastin use

| By HealthLeaders Media Staff
| December 07, 2007

Advisors for the Food and Drug Administration say that Genentech's Avastin cancer drug should not be approved for expanded use in breast-cancer patients.

Full story

Tagged Under:

Most Popular

#1

Researcher: Paxlovid is 'Game Changer' in Treatment of COVID-19

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

Bon Secours Mercy Health Invests in Local Supplier of PPE

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...

Search form

FDA panel votes against new Avastin use

Share this:

Tagged Under:

Most Popular

Researcher: Paxlovid is 'Game Changer' in Treatment of COVID-19

Bon Secours Mercy Health Invests in Local Supplier of PPE

Get the latest on healthcare leadership in your inbox.